Maharashtra records 1,632 new COVID-19 cases, 40 deaths, 1,744 recoveries

With the addition of new cases and deaths, the state's COVID-19 tally rose to 65,99,850, while the toll increased to 1,39,965.On Thursday, the state had recorded 1,573 new coronavirus cases and 39 fatalities.

PTI

October 22, 2021 / 22:23 IST

(Representative image: Reuters)

Maharashtra reported 1,632 new COVID-19 cases, slightly up from a day ago, and 40 fresh fatalities on Friday, while 1,744 patients recovered from the infection in the state, the health department said. Eight districts out of the total 36 did not report any fresh case of the respiratory disease.

With the addition of new cases and deaths, the state's COVID-19 tally rose to 65,99,850, while the toll increased to 1,39,965.On Thursday, the state had recorded 1,573 new coronavirus cases and 39 fatalities.

The case fatality rate in Maharashtra stands at 2.12 percent, the department said. With 1,744 patients discharged from hospitals in the last 24 hours, the number of recovered cases increased to 64,32,138, it said.

There are now 24,138 active cases in the state, whose coronavirus recovery rate stands at 97.46 percent. Currently, 1,98,958 people are in home quarantine and 998 in institutional quarantine, the department said in its bulletin.

Eight districts - Nandurbar, Latur, Parbhani, Gondia, Nagpur, Amravati, Gadchiroli, Wardha - did not record any new case. Areas under the civic bodies of Akola and Amravati also recorded zero cases, it said. Mumbai recorded 420 cases and five deaths, the bulletin said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show